Malignant Hematology![]() |
Find a Doctor![]() Ning Dong, MD, MS
Program: Malignant Hematology
Overview
Dr. Dong received her MD degree from Tongji Medical University, Wuhan, China. She completed a Master of Science in Biomedicine at Pennsylvania State University and a Master of Science in Statistics at Rutgers University, New Brunswick, New Jersey. She completed an Internal Medicine Residency at Rutgers New Jersey Medical School, Newark, and most recently completed a Hematology/Oncology Fellowship at Moffitt Cancer Center/University of South Florida Morsani College of Medicine. Dr. Dong’s clinical interest is in lymphoid malignancies, including B-cell and T-cell lymphomas. As a clinical investigator, her research focuses upon improving treatment outcomes of lymphomas through novel therapeutics, identification of biomarkers to predict responses and interrogating mechanisms of treatment resistance. Education & Training
Participating Trials
CLINICAL TRIAL 21035
If you believe you are eligible for one of these trials or studies, please call
Publications
Grants
Title: Improving cutaneous T-cell lymphoma (CTCL) patient enrollment and diversity in the TELLOMAK trial: T-cell Lymphoma anti-KIR3DL2 therapy, an open label, multi-cohort, multi-center phase II study evaluating the efficacy and safety of IPH4102 alone or in combination with chemotherapy in patients with Advanced T-cell lymphoma
Patient Comments
Overall Satisfaction
4.7
20 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. These surveys assess the experience of our patients when visiting us for an Outpatient Clinic, Urgent Care or Virtual Health (Telemedicine) visit. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Comments ()Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy. We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic. Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months. Learn more about our patient commentsProvider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
|